HOME › DRUGS › REGDANVIMAB
ACTIVE SUBSTANCE / INN

REGDANVIMAB

Brand name(s): Regkirona
EMA LISTED
WITHDRAWN
COVID-19 virus infection
ACTIVE SUBSTANCE
Regdanvimab
REGULATORS
EMA
SPONSORS / MAH
Celltrion Healthcare Hungary Kft.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RegkironaCelltrion Healthcare Hungary Kft.Withdrawn12/11/2021COVID-19 virus infection

FULL INTELLIGENCE ON REGDANVIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →